Artelo Biosciences
ARTL
7 hedge funds and large institutions have $132K invested in Artelo Biosciences in 2026 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and 4 closing their positions.
9.59% more ownership
Funds ownership: 6.32% → 15.91% (+9.6%)
13% less funds holding
Funds holding: 8 → 7 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
84% less capital invested
Capital invested by funds: $830K → $132K (-$698K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$152K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$39.7K |
| 3 |
SG
StoneX Group
New York
|
+$35.5K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$16K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$8.04K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AS
Altshuler Shaham
Tel Aviv,
Israel
|
-$484K |
| 2 |
KCM
Kathmere Capital Management
Wayne,
Pennsylvania
|
-$100K |
| 3 |
Citigroup
New York
|
-$23.3K |
| 4 |
CS
Clear Street
New York
|
-$758 |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$7 |
ARTL Hedge Fund Activity: Q2 2026 in Review
7 of the 8,345 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences (ARTL) for Q2 2026, worth a combined $132K — down 84% from $830K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ARTL and 3 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.
The largest buyer was Jane Street, adding an estimated $152K. The largest seller was Altshuler Shaham, exiting entirely with an estimated $484K sold.
- 7 institutional investors held Artelo Biosciences (ARTL) as of Q2 2026, down from 8 in Q1 2026.
- Funds reported $132K of Artelo Biosciences stock for Q2 2026, down 84% quarter-over-quarter.
- 3 funds opened new Artelo Biosciences positions in Q2 2026 and 4 closed out, a net change of -1 holder.
- The largest Artelo Biosciences buyer in Q2 2026 was Jane Street, an estimated $152K added.
- The largest Artelo Biosciences seller in Q2 2026 was Altshuler Shaham, an estimated $484K sold.
Based on aggregated 13F filings for Q2 2026.